Prova Education designs educational programs that address a broad spectrum of gaps in awareness, attitudes, skills, and competencies related to guideline-based care and evolving disease management options. Its mission is to serve as an innovative and relevant resource for clinical content that promotes change in practice and patient outcomes.
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTRv-PN: A Complicated Disease With a Poor Prognosis
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying